Christie InnoMed to market Accuray products in Canada

Michel VachonMONTREAL – Christie InnoMed Inc. and Accuray Inc., of Sunnyville, Calif., announced that they have entered into sales agent agreements involving the CyberKnife and TomoTherapy System product portfolios in Canada. Under the terms of these agreements, Christie InnoMed will be the exclusive sales agent for Accuray products in this region.

We look forward to a long-term partnership with Accuray and the chance to work with a company focused on providing solutions that help clinicians optimize patient care, said Dr. Michel Vachon (pictured), president and chief executive officer of Christie InnoMed Inc.

The addition of the CyberKnife and TomoTherapy Systems complement our existing product line of radiography imaging equipment. Our extensive market knowledge and deep-seated customer relationships provide us with the opportunity to have a positive impact on new order growth for these clinically proven technologies.

Established in 1954, Christie InnoMed has an extensive knowledge of the Canadian radiosurgery and radiation therapy market from both a product and customer perspective. Covering the Canadian medical market for more than 60 years, they have established strong relationships with clinicians and administrators in many of the cancer centres and hospitals across the country.

Under the new agreements, Christie became eligible to act as sales agent beginning on December 1, 2014. The CyberKnife and TomoTherapy System product lines have set the standard of care for patients requiring radiation therapy. Both systems deliver precise doses of radiation to treat cancerous and non-cancerous tumors throughout the body.

Christie InnoMed is a well-respected organization known for representing high-quality, leading-edge products. By joining forces with Christie, Accuray gains additional market coverage and increased visibility for our precise, innovative CyberKnife and TomoTherapy Systems, said Joshua H. Levine, president and chief executive officer of Accuray.

We expect that our collaboration will significantly enhance our overall selling presence in Canada, ultimately resulting in new order growth and increased patient access to our life-saving technologies moving forward.

About Christie Innomed
Christie InnoMed develops, distributes, integrates and supports technological products and solutions that improve performance of Canadian healthcare institutions in the areas of medical imaging and healthcare management solutions. The Christie InnoMed team helps hospitals and clinics optimize their imaging rooms and enhance their performance in terms of screening, diagnosis and management. Christie InnoMed offers customers extensive technical and clinical support to improve workflows, and optimize use of imaging technology, thereby helping deliver the best care possible.

About the CyberKnife and TomoTherapy Systems
The Accuray CyberKnife M6 Series and TomoTherapy H Series treatment solutions cover the entire spectrum of radiation therapy needs. The CyberKnife M6 Series enables precise, high-quality, dose distributions to be confidently delivered to the patient with extreme accuracy over a minimum number of treatments, reducing side effects and preserving patients’ quality of life. The CyberKnife System is the only robotic full-body radiosurgery system available today. The TomoTherapy H Series efficiently enables physicians to customize treatment plans for the entire range of radiation therapy patients and disease types. Its innovative design enables treatment plans to be delivered with integrated, daily CT image guidance, enhancing accuracy and delivering highly precise, intensity-modulated radiation for optimal sparing of healthy tissue and critical structures.

About Accuray
Accuray Incorporated is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The company’s leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments.

Written by Editor

No comments yet.

No one has left a comment for this post yet!

Leave a comment